Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two WeeksARLINGTON, Mass ...
KALA BIO (KALA) stock soared 70% pre-market after revealing plans to launch its first commercial AI agent in 14 days through ...
On March 3, 2026, KALA BIO entered into a 12‑month Platform Development and Exclusive License Agreement with Younet AI, securing a worldwide exclusive license to the proprietary Researgency biomedical ...
Shares of KALA BIO KALA have nosedived 88.3% in a month after the company announced the failure of a mid-stage study evaluating its only clinical pipeline candidate, KPI-012, for the treatment of ...
・A rescue financing and loan settlement halted an impending asset seizure after Oxford’s default. ・A two-stage preferred stock deal supplies up to $6 million to stabilize operations and restructure ...
A bowl of soaked kala chana never goes out of fashion. True, it does not come in fancy packaging, nor does it boast an elaborate gourmet recipe, but in a world of protein bars and imported superfoods, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results